Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term **adenylate energy pool** does not refer to a molecular entity, gene, protein, or classic drug target but rather to the collective pool of the three adenine nucleotides—ATP, ADP, and AMP—within a biological sample. The "adenylate energy charge" is a metric commonly used to describe the energy status of cells, calculated from the relative levels of these nucleotides: \(\text{AEC} = (\text{[ATP]} + 0.5 \times \text{[ADP]}) / (\text{[ATP]} + \text{[ADP]} + \text{[AMP]})\)[3][4][8]. This measure serves as a widely accepted index of cellular energetic state, reflecting how effectively a cell is balancing energy production and use. While enzymes like **adenylate kinase** act on and regulate these pools, the pool itself is not a molecular structure or target for drugs and cannot be considered a receptor, enzyme, transporter, or conventional therapeutic target[1][2][4]. Thus, it should not be treated as a druggable target or entry in structured databases of molecular targets, and the target entry is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on adenylate energy pool.